SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-026180
Filing Date
2021-11-10
Accepted
2021-11-10 16:41:05
Documents
17
Period of Report
2021-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20211109_8k.htm   iXBRL 8-K 31302
2 EXHIBIT 10.1 ex_305184.htm EX-10.1 209946
3 EXHIBIT 99.1 ex_305185.htm EX-99.1 24086
8 logo01.jpg GRAPHIC 5618
9 logo02.jpg GRAPHIC 3373
  Complete submission text file 0001437749-21-026180.txt   484545

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA govx-20211109.xsd EX-101.SCH 4030
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20211109_def.xml EX-101.DEF 13402
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20211109_lab.xml EX-101.LAB 17563
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20211109_pre.xml EX-101.PRE 13373
10 EXTRACTED XBRL INSTANCE DOCUMENT govx20211109_8k_htm.xml XML 4275
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 211397369
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences